指南与共识免疫规划

免疫功能受损宿主的疫苗接种:意大利原发性免疫缺陷网络中心(IPINET)的建议

Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET).
指南 / 共识 · Vaccine · 2018-02-06

本文由意大利原发性免疫缺陷网络中心(IPINET)发布,针对原发性或继发性免疫缺陷患者疫苗接种缺乏明确证据的现状,基于已发表文献和各中心的集体经验,提出关于免疫功能受损患者如何及何时接种疫苗的建议,以帮助医生决策,在确保最佳免疫保护的同时将风险降至最低。

要点

  • 感染性并发症是原发性或继发性免疫缺陷患者发病和死亡的主要原因。
  • 疫苗接种是预防感染最有效的医疗措施之一,尤其对这类患者。
  • 免疫功能受损人群的免疫抑制程度和易感性各异,疫苗接种无明确循证依据,本文件基于文献和意大利各中心经验提出建议。

核心结论

  • 本文件基于已发表文献和意大利原发性免疫缺陷中心的集体经验,提出关于免疫功能受损患者如何及何时接种疫苗的建议,以帮助医生决策,在确保最佳免疫保护的同时将风险降至最低。

研究设计与样本

  • 意大利原发性免疫缺陷网络中心(IPINET)制定,基于已发表文献和各中心的集体经验提出建议。

临床怎么用

  • 原文未据此给出具体临床推荐。

局限性

  • 原文指出,迄今为止尚无关于免疫缺陷患者使用疫苗的充分证据,即使在高质量的综述和大多数为免疫功能受损宿主主动疫苗接种提供建议的指南中,适应证也未明确界定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Infectious complications are a major cause of morbidity and mortality in patients with primary or secondary immunodeficiency. Prevention of infectious diseases by vaccines is among the most effective healthcare measures mainly for these subjects. However immunocompromised people vary in their degree of immunosuppression and susceptibility to infection and, therefore, represent a heterogeneous population with regard to immunization. To date there is no well- established evidence for use of vaccines in immunodeficient patients, and indications are not clearly defined even in high-quality reviews and in most of the guidelines prepared to provide recommendations for the active vaccination of immunocompromised hosts. The aim of this document is to issue recommendations based on published literature and the collective experience of the Italian primary immunodeficiency centers, about how and when vaccines can be used in immunocompromised patients, in order to facilitate physician decisions and to ensure the best immune protection with the lowest risk to the health of the patient.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Martire B, Azzari C, Badolato R, et al. Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET). Vaccine. 2018. PMID: 29426658. doi:10.1016/j.vaccine.2018.01.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。